{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:01:18Z","timestamp":1791558078478,"version":"4.3.4"},"reference-count":18,"publisher":"American Medical Association (AMA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2018.0919","type":"journal-article","created":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T18:03:23Z","timestamp":1529690603000},"page":"e180919","source":"Crossref","is-referenced-by-count":143,"title":["Exposure-Response Association Between Concurrent Opioid and Benzodiazepine Use and Risk of Opioid-Related Overdose in Medicare Part D Beneficiaries"],"prefix":"10.1001","volume":"1","author":[{"given":"Inmaculada","family":"Hernandez","sequence":"first","affiliation":[{"name":"Department of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqi","family":"He","sequence":"additional","affiliation":[{"name":"Department of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria M.","family":"Brooks","sequence":"additional","affiliation":[{"name":"Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Health Policy and Management, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2018,6,22]]},"reference":[{"issue":"5","key":"zoi180066r1","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/jama.2017.8913","article-title":"New data on opioid use and prescribing in the United States.","volume":"318","author":"Schuchat","year":"2017","journal-title":"JAMA"},{"issue":"5051","key":"zoi180066r2","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.15585\/mmwr.mm655051e1","article-title":"Increases in drug and opioid-involved overdose deaths\u2014United States, 2010-2015.","volume":"65","author":"Rudd","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"zoi180066r3","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.jpain.2011.11.004","article-title":"Concurrent use of alcohol and sedatives among persons prescribed chronic opioid therapy: prevalence and risk factors.","volume":"13","author":"Saunders","year":"2012","journal-title":"J Pain"},{"issue":"15","key":"zoi180066r4","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016.","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"key":"zoi180066r6","doi-asserted-by":"publisher","first-page":"j760","DOI":"10.1136\/bmj.j760","article-title":"Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis.","volume":"356","author":"Sun","year":"2017","journal-title":"BMJ"},{"key":"zoi180066r7","doi-asserted-by":"publisher","first-page":"h2698","DOI":"10.1136\/bmj.h2698","article-title":"Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study.","volume":"350","author":"Park","year":"2015","journal-title":"BMJ"},{"issue":"6","key":"zoi180066r8","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/ADM.0000000000000245","article-title":"Understanding risk factors for opioid overdose in clinical populations to inform treatment and policy.","volume":"10","author":"Park","year":"2016","journal-title":"J Addict Med"},{"issue":"5","key":"zoi180066r9","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1001\/jamainternmed.2013.12809","article-title":"Sources of prescription opioid pain relievers by frequency of past-year nonmedical use: United States, 2008-2011.","volume":"174","author":"Jones","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"3","key":"zoi180066r10","first-page":"235","article-title":"Reducing fatal opioid overdose: prevention, treatment and harm reduction strategies.","volume":"88","author":"Hawk","year":"2015","journal-title":"Yale J Biol Med"},{"issue":"5","key":"zoi180066r11","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1001\/jamainternmed.2013.12711","article-title":"High-risk use by patients prescribed opioids for pain and its role in overdose deaths.","volume":"174","author":"Gwira Baumblatt","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"6","key":"zoi180066r14","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1185\/03007991003772096","article-title":"Prescription patterns of antidepressants: findings from a US claims database.","volume":"26","author":"Milea","year":"2010","journal-title":"Curr Med Res Opin"},{"issue":"12","key":"zoi180066r15","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1016\/j.clinthera.2013.09.006","article-title":"Diagnoses associated with use of atypical antipsychotics in a commercial health plan: a claims database analysis.","volume":"35","author":"Citrome","year":"2013","journal-title":"Clin Ther"},{"issue":"1","key":"zoi180066r16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1056\/NEJMsa1514387","article-title":"State legal restrictions and prescription-opioid use among disabled adults.","volume":"375","author":"Meara","year":"2016","journal-title":"N Engl J Med"},{"key":"zoi180066r5","unstructured":"CrawfordC. FDA requires new warnings on combined opioid, benzodiazepine use. American Academy of Family Physicians. http:\/\/www.aafp.org\/news\/health-of-the-public\/20160907opioid-benzos.html. Published September 7, 2016. Accessed November 15, 2017."},{"key":"zoi180066r12","unstructured":"Centers for Medicare and Medicaid Services. Concurrent use of opioids and benzodiazepines in a Medicare Part D population. https:\/\/www.cms.gov\/Medicare\/Prescription-Drug-Coverage\/PrescriptionDrugCovContra\/Downloads\/Concurrent-Use-of-Opioids-and-Benzodiazepines-in-a-Medicare-Part-D-Population-CY-2015.pdf. Published May 12, 2016. Accessed November 13, 2017."},{"key":"zoi180066r13","unstructured":"Center for Medicare and Medicaid Services Chronic Conditions Data Warehouse. 27 chronic condition algorithm. https:\/\/www.ccwdata.org\/web\/guest\/condition-categories. Updated November 2017. Accessed April 26, 2017."},{"key":"zoi180066r17","unstructured":"Pharmacy Quality Alliance (PQA). PQA performance measures. http:\/\/pqaalliance.org\/measures\/default.asp. Accessed November 30, 2017."},{"key":"zoi180066r18","unstructured":"Centers for Disease Control and Prevention. What states need to know about PDMPs. https:\/\/www.cdc.gov\/drugoverdose\/pdmp\/states.html. Updated October 3, 2017. Accessed April 4, 2018."}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamanetworkopen\/article-pdf\/1\/2\/e180919\/17326726\/hernandez_2018_oi_180066.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T20:49:43Z","timestamp":1551214183000},"score":1,"resource":{"primary":{"URL":"http:\/\/jamanetworkopen.jamanetwork.com\/article.aspx?doi=10.1001\/jamanetworkopen.2018.0919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,22]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.0919","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,22]]}}}